On-Demand Webinar
Transitioning From Discovery to Lead Optimization: Peptide Synthesis Applications in Modern Peptide Drug Development
Join William C. Blackwell III, Director of Chemistry at Atkins Oncology, as he shares insights from his extensive experience in peptide drug discovery, including successful GLP-1 receptor agonist programs. Learn how leading organizations optimize their peptide development pathway to capitalize on this multi-billion market opportunity.
Key Insights:
- Strategic approaches to hit-to-lead optimization that delivered successful GLP-1 therapeutic candidates
- Critical success factors in scaling peptide synthesis while maintaining quality
- Real-world case studies of program development, including optimization of Amylin agonists
- Practical strategies for building effective multi-disciplinary development teams
This presentation delivers actionable insights for organizations looking to enter or expand their presence in the rapidly growing peptide therapeutics market.
Speaker:
William C Blackwell III, Director of Chemistry, Aktis Oncology, RTP, NC
If you have problems viewing the webinar, please contact maritha.lundin@gyrosproteintech.com